Sandra Herrmann MD, FASN
@HerrmannMd
Nephrologist @MayoClinicNeph. Professor of Medicine @mayoclinic. Tweets are my own.
Can’t wait to see you all in Rochester. Join us Sept 11-12 of 2025. @PepaSolerR @ShrutiGkidney @rc_oncneph @onconeph @k1dneyMD @LeticiaRolonMD @basmeomeo @delphile @AbdullahJalalMD @itunuowoyemi @MPAlexanderMD @bdubNephro @MayoClinicNeph @AleksandraKukl9
Onco-Nephrology Symposium on September 11-12, 2025. Please join us for this exciting event ( In- person or virtually). Register here: ce.mayo.edu/nephrology/con… @HerrmannMd @k1dneyMD @LeticiaRolonMD
Membranous nephropathy has undergone a paradigm shift due to the discovery of unique MN antigens. MN has gone from idiopathic to ➡️ primary vs. secondary ➡️ where an antigen can be detected in ~80% of MN. This is a comprehensive review of each antigen. nature.com/articles/s4158…
A new study in #ASNJASN highlights associations between circulating proteins and kidney stone diagnosis. Lower circulating UMOD and higher SSC4D levels are associated with increased kidney stone risk, while kidney stone presence elevates plasma MMP7 level. kidney.pub/JASN0768
#AI Reporting Standards in Clinical Research: Choosing the Right Guideline 📕 As AI increasingly shapes the landscape of clinical research, transparent and standardized reporting becomes essential. This guide outlines a practical framework for selecting the appropriate…
In our newest study from Dr. @GarovicVesna’s lab we showed that changes in the vascular glycocalyx during pregnancy are linked to urinary podocyte markers, suggesting early endothelial injury may contribute to kidney stress even in normal pregnancies. ahajournals.org/doi/10.1161/JA…
Clinical trial at our Mayo Clinic Nephrology: Evaluating daratumumab for treatment of PGNMID (Proliferative Glomerulonephritis with Monoclonal Immune Deposits). A novel approach to a rare glomerular disease. @fervenzafernan1 @LadanZand Learn More🔗 mayo.edu/research/clini…
🎥🎥🎥 “𝟏𝐫𝐬𝐭 𝐌𝐚𝐲𝐨 𝐂𝐥𝐢𝐧𝐢𝐜 - 𝐕𝐚𝐥𝐥 𝐝’𝐇𝐞𝐛𝐫𝐨𝐧 𝐍𝐄𝐏𝐇𝐑𝐎𝐋𝐎𝐆𝐘 𝐔𝐏𝐃𝐀𝐓𝐄” 5-6 Sep BCN 2025. Register to [email protected] organized by @MayoClinicNeph @NefrologiaVH @vallhebron @HerrmannMd @OriolBestard @fervenzafernan1 @JuancaLeonRoman
🦀 Ever wondered how to navigate VEGFi-induced proteinuria or TMA in cancer patients? 🧬 #OncoNephrology CKJ review breaks it down! 🩺 Involve #Nephrology early, avoid non-DHP CCBs & track BP/UPCR closely! 📖 doi.org/10.1093/ckj/sf… 🆕 #MedX #NephTwitter #HTN #VEGFi #Oncology
🩺Diagnosis and Mx of AKI on immune checkpoint inhibitors? 🔪When to biopsy? 💉 Steroid or spare? 💊Mycophenolate vs infliximab? #OncoNephrology 🦀 @HerrmannMd #AKI #ImmuneRelatedAE #NephTwitter #Nephrology #MedX 📖 doi.org/10.1093/ckj/sf… 🆕
Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease @LadanZand @SethiRenalPath @fervenzafernan1 @PepaSolerR @martacasalmoura #MayoClinicKidney academic.oup.com/ndt/advance-ar…
Male patients with AAV-GN and eGFR <15 start dialysis earlier than female. However, progression to ESKD at 12 months is not different. This is associated with chronic changes in kidney histopathology but not with sex @PepaSolerR @fervenzafernan1 @SethiRenalPath @MayoClinicNeph✨
Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease doi.org/10.1093/ndt/gf…
🙏🏻😊 Happy to share our latest piece in the July issue of @asnpublications ASN Kidney News! doi.org/10.62716/kn.00… Andrea Angioi @andreaangioi , Cristina Popa @NephroSeeker and I—summarize highlights from the 62nd European Renal Association (ERA) @ERAkidney Congress in…
Mayo Clinic is pleased to announce a two-day course on Sept 11-12, the Onco-Nephrology Symposium 2025, introduces the latest updates & advances in the field of onco nephrology. Please join us for this exciting event! To learn more, click here ce.mayo.edu/nephrology/con…
Kidney News July 2025 @asnpublications Clinical Practice Guidelines for Genetic Testing in ADPKD Neera K. Dahl @pranavgarimella and Fouad T. Chebib kidneynews.org/view/journals/…
𝐓𝐨𝐝𝐨𝐬 𝐬𝐨𝐦𝐨𝐬 𝐒.𝐄.𝐍. Una candidatura ABIERTA, donde TODOS somos los protagonistas!! Contamos contigo, súmate a nuestro proyecto. @SENefrologia @SEDENenfermeria @FundacionRenalE @FNALCER @ERAkidney @ONT_esp @ISNkidneycare @asnpublications @SLANH_
Clinicopathological Characteristics and Long-Term Kidney Outcomes in Biopsy-Proven Renal Sarcoidosis @jingmiao2019 @wisit661 @LadanZand @fervenzafernan1 #MayoClinicKidney journals.lww.com/kidney360/abst…
🎥🎥🎥 “𝟏𝐫𝐬𝐭 𝐌𝐚𝐲𝐨 𝐂𝐥𝐢𝐧𝐢𝐜 - 𝐕𝐚𝐥𝐥 𝐝’𝐇𝐞𝐛𝐫𝐨𝐧 𝐍𝐄𝐏𝐇𝐑𝐎𝐋𝐎𝐆𝐘 𝐔𝐏𝐃𝐀𝐓𝐄” 5-6 Sep Barcelona 2025. Register to [email protected] organized by @MayoClinicNeph @NefrologiaVH @vallhebron @HerrmannMd @OriolBestard @fervenzafernan1 @ConxitaJacobs
Save the date 🌟🌟 Onconephrology symposium 2025 @MayoClinic @HerrmannMd @LeticiaRolonMD @k1dneyMD
Onco-Nephrology Symposium on September 11-12, 2025. Please join us for this exciting event ( In- person or virtually). Register here: ce.mayo.edu/nephrology/con… @HerrmannMd @k1dneyMD @LeticiaRolonMD
Onco-Nephrology Symposium on September 11-12, 2025. Please join us for this exciting event ( In- person or virtually). Register here: ce.mayo.edu/nephrology/con… @HerrmannMd @k1dneyMD @LeticiaRolonMD